Marble Wealth LLC Makes New Investment in HCA Healthcare, Inc. $HCA

Marble Wealth LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,462 shares of the company’s stock, valued at approximately $683,000.

Other hedge funds also recently bought and sold shares of the company. Brighton Jones LLC bought a new stake in shares of HCA Healthcare during the fourth quarter worth $1,021,000. NewEdge Advisors LLC increased its position in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares in the last quarter. Sivia Capital Partners LLC increased its position in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares in the last quarter. Jump Financial LLC bought a new stake in shares of HCA Healthcare during the second quarter worth $2,073,000. Finally, Sei Investments Co. grew its position in HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

Shares of HCA opened at $364.00 on Thursday. The firm has a 50-day moving average of $444.21 and a 200-day moving average of $478.72. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The company has a market cap of $80.75 billion, a PE ratio of 12.52, a price-to-earnings-growth ratio of 1.16 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on HCA. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. UBS Group raised their target price on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. Argus decreased their target price on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Mizuho raised their target price on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research report on Tuesday, April 28th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $515.77.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.